MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 596906 | Name: Erythromycin aspartate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Erythromycin aspartate is an enzyme.

Chemical Structure

Erythromycin aspartate
Erythromycin aspartate
CAS#30010-41-4 (aspartate)

Theoretical Analysis

MedKoo Cat#: 596906

Name: Erythromycin aspartate

CAS#: 30010-41-4 (aspartate)

Chemical Formula: C41H74N2O17

Exact Mass: 866.4987

Molecular Weight: 867.04

Elemental Analysis: C, 56.80; H, 8.60; N, 3.23; O, 31.37

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
7704-67-8 (thiocyanate) 114-07-8 (free base) 30010-41-4 (aspartate) 14271-02-4 (HCl) 16667-03-1 (glutamate) 3521-62-8 (estolate) 914076-30-5 (ethyl carbonate) 134-36-1 (propionate) 1264-62-6 (ethylsuccinate) 23067-13-2 (Gluceptate)
Synonym
Erythromycin aspartate; Erythromycin L-aspartate;
IUPAC/Chemical Name
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione L-aspartate
InChi Key
MVGQXQJJZQSBPZ-SVCGJITISA-N
InChi Code
InChI=1S/C37H67NO13.C4H7NO4/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;5-2(4(8)9)1-3(6)7/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;2H,1,5H2,(H,6,7)(H,8,9)/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-;2-/m10/s1
SMILES Code
CC[C@H]1OC([C@@H]([C@H]([C@@H]([C@H]([C@](O)(C[C@H](C([C@@H]([C@H]([C@@]1(O)C)O)C)=O)C)C)O[C@@H]2O[C@@H](C[C@H](N(C)C)[C@H]2O)C)C)O[C@H]3C[C@@](OC)([C@H]([C@@H](O3)C)O)C)C)=O.N[C@H](C(O)=O)CC(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 867.04 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Stoianova-Zaĭkova L, Doneva M. [Blood concentrations and anti-Borrelia anserina activity of erythromycin salts in birds]. Vet Med Nauki. 1982;19(1):97-103. Bulgarian. PubMed PMID: 7112926. 2: Doneva M, Bineva I. [Pharmacokinetic and microbiological studies of Pharmachem erythromycin asparate]. Vet Med Nauki. 1979;16(9):58-64. Bulgarian. PubMed PMID: 120997. 3: Di Nucci A, Gregotti C, Richelmi P, Manzo L, Bertè F. [Metabolism of erythromycin and erythromycin aspartate in the microsomal fraction of the rat liver]. Boll Soc Ital Biol Sper. 1976 Dec 30;52(24):2115-9. Italian. PubMed PMID: 1030960. 4: Manzo L, Di Nucci A, Richelmi P, Gregotti C, Bertè F. [Effects of phenobarbital on the distribution of erythromycin and erythromycin aspartate in the rat]. G Ital Chemioter. 1976 Jan-Jun;23(1):3-7. Italian. PubMed PMID: 1029694. 5: Casilli L, Vacca C, Castaldi S, Caliendo RA. [Experimental research on erythromycin aspartate]. Boll Chim Farm. 1972 Apr;111(4):239-49. Italian. PubMed PMID: 5042327.